NEOGRADE
LIVE

Serial Number

79434488

Owner

Cyted Limited

Attorney

Bruce S. Londa

Filing Date

Sep 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NEOGRADE Trademark

Serial Number: 79434488

NEOGRADE is a trademark filed by Cyted Limited on September 8, 2025. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Cyted Limited (3 trademarks)

22 Station Road

Entity Type: 98

Trademark Details

Filing Date

September 8, 2025

Registration Date

Not Registered

Published for Opposition

August 25, 2026

Goods & Services

medical diagnostic services in the field of gastroenterology; medical testing services in the field of gastroenterology; medical advisory services in the field of gastroenterology; medical treatment services for the treatment of gastrointestinal disease; medical analysis services relating to the treatment of patients having gastrointestinal disease; medical and healthcare clinics services in the field of gastroenterology; providing medical information regarding testing and diagnosis of gastrointestinal disease; providing medical information regarding diagnosis and treatment of gastrointestinal disease

Medical apparatus and instruments for use in esophogeal procedures; medical devices for use in diagnosing gastrointestinal diseases; diagnostic instruments for medical use, namely, capsule sponge for collecting cells from the lining of the esophagus

Medical research services in the field of gastroenterology; pharmacological research services; medical research laboratories in the field of gastroenterology; medical research laboratory services in the field of gastroenterology; medical research laboratory services in the field of gastroenterology; software as a service (SaaS) featuring software for database management in the field of gastroenterology; software as a service (SaaS) featuring software platforms for artificial intelligence for diagnosis and treatment of gastrointestinal diseases; Software as a service (SAAS) services featuring software for computer aided diagnostic testing services for the medical industry in the field of gastroenterology; design and design and development of medical technology for diagnosis and treatment of gastrointestinal diseases; design and development of diagnostic apparatus, namely, capsule sponge for collecting cells from the lining of the esophogus; biomedical research services in the field of gastroenterology; calibration services relating to medical apparatus; providing scientific research information in the field of gastrointestinal diseases and their treatment

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 5, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 5, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 24, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 20, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 27, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 26, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 21, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 9, 2025 REPR